

Inipharm, a developer of therapies for liver and related diseases, has secured $35 million in Series A financing. The investors were 5AM Ventures, Wu Capital, Frazier Healthcare Partners and Jubilant Biosys Limited.
Source: Press Release
Inipharm, a developer of therapies for liver and related diseases, has secured $35 million in Series A financing.
Inipharm, a developer of therapies for liver and related diseases, has secured $35 million in Series A financing. The investors were 5AM Ventures, Wu Capital, Frazier Healthcare Partners and Jubilant Biosys Limited.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination